Abstract
γ-Aminobutyric acid type A and glycine receptors (GABA(A)Rs, GlyRs) are the major inhibitory neurotransmitter receptors and contribute to many synaptic functions, dysfunctions and human diseases. GABA(A)Rs are important drug targets regulated by direct interactions with the scaffolding protein gephyrin. Here we deduce the molecular basis of this interaction by chemical, biophysical and structural studies of the gephyrin-GABA(A)R α3 complex, revealing that the N-terminal region of the α3 peptide occupies the same binding site as the GlyR β subunit, whereas the C-terminal moiety, which is conserved among all synaptic GABA(A)R α subunits, engages in unique interactions. Thermodynamic dissections of the gephyrin-receptor interactions identify two residues as primary determinants for gephyrin's subunit preference. This first structural evidence for the gephyrin-mediated synaptic accumulation of GABA(A)Rs offers a framework for future investigations into the regulation of inhibitory synaptic strength and for the development of mechanistically and therapeutically relevant compounds targeting the gephyrin-GABA(A)R interaction.
Originalsprog | Engelsk |
---|---|
Artikelnummer | 5767 |
Tidsskrift | Nature Communications |
Vol/bind | 5 |
Sider (fra-til) | 1-11 |
Antal sider | 11 |
ISSN | 2041-1723 |
DOI | |
Status | Udgivet - 22 dec. 2014 |
Fingeraftryk
Dyk ned i forskningsemnerne om 'Molecular basis of the alternative recruitment of GABA(A) versus glycine receptors through gephyrin'. Sammen danner de et unikt fingeraftryk.Presse/Medier
-
Würzburger Forscher entschlüsseln die molekularen Grundlagen der Architektur inhibitorischer Synapsen und den damit verbundenen Gehirnfunktionen und ermöglichen so die Entwicklung verbesserter pharmakologischer Wirkstoffe.: DOI: 10.13140/2.1.1130.5287
Hans Michael Maric
27/01/2015
1 Mediebidrag
Presse/medie
-
New drug design enhances brain signalling by a factor of 1,000: Chemicalbiological research from the University of Copenhagen sheds light on important communication processes in the brain
Hans Michael Maric
06/01/2015
1 Mediebidrag
Presse/medie